Eli Lilly Stock: Is It Still a Buy at $1,400?
The company just released some incredible quarterly results, but its valuation is also fairly high.
Full story
Read the full story at The Motley Fool ↗
Continue reading this story on The Motley Fool, the publisher that reported it.
AI tools
Written by AI from the article text. It can make mistakes; check the original story.
